Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.68 |
| ▸ | NPC1 | O15118 | 6/20 | 0.68 |
| ▸ | RAB9A | P51151 | 5/20 | 0.68 |
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.45 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.44 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14603034 | 1.00 | MEN1 (0.68) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL23257776 | 0.86 | MEN1 (0.53) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL10602984 | 0.86 | MEN1 (0.53) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL11004070 | 0.86 | MEN1 (0.53) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL6123887 | 0.85 | MEN1 (0.50) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL2926925 | 0.84 | MEN1 (0.55) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| Azobenzene SCHEMBL11130609 | 0.84 | MEN1 (0.55) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL2926928 | 0.84 | MEN1 (0.55) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| Azobenzene SCHEMBL11226032 | 0.84 | MEN1 (0.55) | MEN1KMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL28219746 | 0.84 | MEN1 (0.49) | MEN1KMT2AL3MBTL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11384381-B2 | Reaction accelerating agent | KIKKOMAN CORPORATION (JP) | 2022-07-12 | — | — | US | disclosed |
| US-20190316174-A1 | REACTION ACCELERATING AGENT | KIKKOMAN CORPORATION (JP) | 2019-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384381-B2 | Reaction accelerating agent | MPO, AOX1, MAOA | MEN1 3767/4885KMT2A 1992/4885L3MBTL1 4849/4885 |
| US-20190316174-A1 | REACTION ACCELERATING AGENT | MPO, AOX1, MAOA | MEN1 3767/4885KMT2A 1992/4885L3MBTL1 4849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.